{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:02:51Z","timestamp":1781625771141,"version":"3.54.5"},"reference-count":58,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI169674"],"award-info":[{"award-number":["R01AI169674"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This systematic review aimed to establish if higher-valent conjugate vaccines will provide significantly higher coverage and protection in high-risk groups than the 13-valent pneumococcal conjugate vaccine (PCV13). The PubMed, Science Direct, and Google Scholar search engines were searched for original articles that reported on the type of study, period of the study, high-risk group(s) involved, specimens collected, number of isolates, frequency of serotyped isolates, and serotypes\/serogroups of isolates for inclusion. Data from 14 studies based in seven countries, and 789 serotyped\/serogrouped isolates, were extracted. There was no significant difference (P = .23) between the frequency of the non-vaccine serotypes (51.6%) and the vaccine serotypes (48.4%). The 23-valent pneumococcal polysaccharide vaccine (PPV23) had the highest serotype coverage (36.5% \u00b1 5.3%) identified among the high-risk groups. The serotype coverage of the vaccines was highest for the cancer group (26.2% to 40.5%) and lowest for the sickle cell disease group (20% to 28.9%). Higher-valent pneumococcal vaccines may provide significantly higher coverage for groups at a high risk of invasive pneumococcal diseases. There is a need to monitor the serotypes associated with high-risk groups.<\/jats:p>","DOI":"10.1093\/inthealth\/ihag058","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:50:01Z","timestamp":1780055401000},"source":"Crossref","is-referenced-by-count":0,"title":["Serotypes associated with invasive pneumococcal disease high-risk groups: a systematic review"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-4694","authenticated-orcid":false,"given":"Reuben E","family":"Arhin","sequence":"first","affiliation":[{"name":"University of Ghana Medical School Department of Medical Microbiology, , P. O. Box KB 4236, Korle Bu, Accra ,","place":["Ghana"]},{"name":"Accra Technical University Department of Science Laboratory Technology, , P. O. Box GP 561, Barnes Road, Accra ,","place":["Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4491-6902","authenticated-orcid":false,"given":"Nicholas T K D","family":"Dayie","sequence":"additional","affiliation":[{"name":"University of Ghana Medical School Department of Medical Microbiology, , P. O. Box KB 4236, Korle Bu, Accra ,","place":["Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-0636","authenticated-orcid":false,"given":"Eric S","family":"Donkor","sequence":"additional","affiliation":[{"name":"University of Ghana Medical School Department of Medical Microbiology, , P. O. Box KB 4236, Korle Bu, Accra ,","place":["Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2026061610565024600_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fmicb.2017.00217","article-title":"Nasopharyngeal and oropharyngeal colonization by Staphylococcus aureus and Streptococcus pneumoniae and prognostic markers in children with sickle cell disease from the Northeast of Brazil","volume":"8","author":"Rocha","year":"2017","journal-title":"Front Microbiol"},{"key":"2026061610565024600_bib2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cit640","article-title":"Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies","volume":"57","author":"Luj\u00e1n","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026061610565024600_bib3","first-page":"27","article-title":"A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2026061610565024600_bib4","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"2026061610565024600_bib5","first-page":"91","article-title":"Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases","volume":"26","author":"Rivera-Olivero","year":"2014","journal-title":"Int J Infect Dis"},{"key":"2026061610565024600_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jmii.2023.01.013","article-title":"Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: a multicenter observational study","volume":"56","author":"Aydin","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"2026061610565024600_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12941-023-00565-3","article-title":"Genetic determinants of macrolide and tetracycline resistance in penicillin non-susceptible Streptococcus pneumoniae isolates from people living with HIV in Dar es Salaam, Tanzania","volume":"22","author":"Manyahi","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2026061610565024600_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/INF.0000000000003748","article-title":"Invasive pneumococcal disease in high-risk children: a 10-year retrospective study","volume":"42","author":"Van\u00a0Warmerdam","year":"2023","journal-title":"Pediatr Infect Dis J"},{"key":"2026061610565024600_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000000689","article-title":"Schmoele-Thoma B. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination","volume":"29","author":"Bhorat","year":"2015","journal-title":"AIDS"},{"key":"2026061610565024600_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.chom.2014.04.005","article-title":"Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions","volume":"15","author":"Carter","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2026061610565024600_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jinf.2015.07.004","article-title":"Impact of vaccination on IPD in adults with focus on the immunosuppressed","volume":"71","author":"Sangil","year":"2015","journal-title":"J Infect"},{"key":"2026061610565024600_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun"},{"key":"2026061610565024600_bib13","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1080\/21645515.2019.1621068","article-title":"The complexity of serotype replacement of pneumococci","volume":"15","author":"Dobay","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2026061610565024600_bib14","doi-asserted-by":"crossref","first-page":"e0176723","DOI":"10.1371\/journal.pone.0176723","article-title":"Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine","volume":"12","author":"Paulo","year":"2017","journal-title":"PLoS One"},{"key":"2026061610565024600_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood IPD in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026061610565024600_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S2352-4642(23)00025-1","article-title":"Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial","volume":"7","author":"Olwagen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026061610565024600_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/bloodadvances.2022008037","article-title":"Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study","volume":"7","author":"Quinn","year":"2023","journal-title":"Blood Adv"},{"key":"2026061610565024600_bib18","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1016\/S2352-3018(25)00165-1","article-title":"Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trial","volume":"12","author":"Pathirana","year":"2025","journal-title":"Lancet HIV"},{"key":"2026061610565024600_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.htct.2019.06.006","article-title":"Bacterial meningitis in patients with sickle cell anemia in Salvador, Bahia, Brazil: a report on ten cases","volume":"42","author":"Chenou","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"key":"2026061610565024600_bib20","doi-asserted-by":"crossref","first-page":"e0206728","DOI":"10.1371\/journal.pone.0206728","article-title":"Pneumococcal carriage among sickle cell disease patients in Accra, Ghana: risk factors, serotypes and antibiotic resistance","volume":"13","author":"Dayie","year":"2018","journal-title":"PLoS One"},{"key":"2026061610565024600_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26713","article-title":"IPD in children with sickle cell disease in the pneumococcal conjugate vaccine era","volume":"65","author":"Martin","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2026061610565024600_bib22","first-page":"341","volume-title":"J Pediatr Hematol Oncol","author":"Navalkele"},{"key":"2026061610565024600_bib23","doi-asserted-by":"crossref","first-page":"673392","DOI":"10.3389\/fimmu.2021.673392","article-title":"Immunogenicity and efficacy of pneumococcal conjugate vaccine (Prevenar13\u00ae) in preventing acquisition of carriage of pneumococcal vaccine serotypes in Tanzanian children with HIV\/AIDS","volume":"12","author":"Makenga","year":"2021","journal-title":"Front Immunol"},{"key":"2026061610565024600_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jiph.2016.01.004","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in adults infected with human immunodeficiency virus in Jakarta, Indonesia","volume":"9","author":"Harimurti","year":"2016","journal-title":"J Infect Public Health"},{"key":"2026061610565024600_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3427174","article-title":"Epidemiology of pneumococcal carriage among HIV-infected individuals in the conjugate vaccine era: a study in southern Ghana","volume":"2019","author":"Dayie","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026061610565024600_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bjid.2020.09.003","article-title":"IPD in children with cancer: incidence density, risk factors and isolated serotypes","volume":"24","author":"Lages","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"2026061610565024600_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21149\/8159","article-title":"Streptococcus pneumoniae: distribution of serotypes and antimicrobial susceptibility in patients with cancer","volume":"60","author":"Soto-Noguer\u00f3n","year":"2018","journal-title":"Salud Publica Mex"},{"key":"2026061610565024600_bib28","first-page":"221","article-title":"Invasive and complicated pneumococcal infection in patients with cancer","volume":"68","author":"Zarco-M\u00e1rquez","year":"2016","journal-title":"Rev Invest Clin"},{"key":"2026061610565024600_bib29","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3346\/jkms.2017.32.10.1581","article-title":"Validation of the World Health Organization enzyme-linked immunosorbent assay for the quantitation of immunoglobulin G serotype-specific anti-pneumococcal antibodies in human serum","volume":"32","author":"Lee","year":"2017","journal-title":"J Korean Med Sci"},{"key":"2026061610565024600_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/microorganisms9040795","article-title":"Genome-wide analysis of the temporal genetic changes in streptococcus pneumoniae isolates of genotype st320 and serotype 19a from South Korea","volume":"9","author":"Baek","year":"2021","journal-title":"Microorganisms"},{"key":"2026061610565024600_bib31","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1038\/s41598-022-11279-5","article-title":"Evidence for the intermediate disturbance hypothesis and exponential decay in replacement in Streptococcus pneumoniae following use of conjugate vaccines","volume":"12","author":"Paulo","year":"2022","journal-title":"Sci Rep"},{"key":"2026061610565024600_bib32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/cid\/ciz404","article-title":"Early signals of vaccine-driven perturbation seen in pneumococcal carriage population genomic data","volume":"70","author":"Chaguza","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026061610565024600_bib33","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"2026061610565024600_bib34","first-page":"e01822","article-title":"Whole-genome sequence analysis of Streptococcus pneumoniae strains that cause hospital-acquired pneumonia infections","volume":"56","author":"Chang","year":"2018","journal-title":"PubMLST"},{"key":"2026061610565024600_bib35","doi-asserted-by":"crossref","first-page":"543898","DOI":"10.3389\/fpubh.2020.543898","article-title":"Characterization of pneumococcal colonization dynamics and antimicrobial resistance using shotgun metagenomic sequencing in intensively sampled South African infants","volume":"8","author":"Manenzhe","year":"2020","journal-title":"Front Public Health"},{"key":"2026061610565024600_bib36","doi-asserted-by":"crossref","first-page":"615924","DOI":"10.3389\/fmicb.2021.615924","article-title":"Streptococcus pneumoniae type 1 Pilus\u2014a multifunctional tool for optimized host interaction","volume":"12","author":"Ness","year":"2021","journal-title":"Front Microbiol"},{"key":"2026061610565024600_bib37","doi-asserted-by":"crossref","first-page":"e1006665","DOI":"10.1371\/journal.ppat.1006665","article-title":"The immunological mechanisms that control pneumococcal carriage","volume":"13","author":"Jochems","year":"2017","journal-title":"PLoS Pathog"},{"key":"2026061610565024600_bib38","doi-asserted-by":"crossref","first-page":"e0133885","DOI":"10.1371\/journal.pone.0133885","article-title":"Virulence factors of Streptococcus pneumoniae. Comparison between African and French invasive isolates and implication for future vaccines","volume":"10","author":"Blumental","year":"2015","journal-title":"PLoS One"},{"key":"2026061610565024600_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/toxins13020157","article-title":"Streptococcus pneumoniae and its virulence factors H2O2 and pneumolysin are potent mediators of the acute chest syndrome in sickle cell disease","volume":"13","author":"Gonzales","year":"2021","journal-title":"Toxins"},{"key":"2026061610565024600_bib40","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/clinids\/14.5.1124","article-title":"Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination","volume":"14","author":"Wong","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2026061610565024600_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6161270","article-title":"Burden of sickle cell disease in Ghana: the Korle-Bu experience","volume":"2018","author":"Asare","year":"2018","journal-title":"Adv Hematol"},{"key":"2026061610565024600_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.aller.2019.04.003","article-title":"Comparison of pneumococcal vaccination response in children with sickle cell disease: HbSS and HbSC","volume":"47","author":"le\u00a0Ng","year":"2019","journal-title":"Allergol Immunopathol"},{"key":"2026061610565024600_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/516781","article-title":"Incidence of IPD among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine","volume":"44","author":"Halasa","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026061610565024600_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1086\/517535","article-title":"Pneumococcus and sickle cell disease: the beginning of the end?","volume":"44","author":"Steinberg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026061610565024600_bib45","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/MPH.0000000000000510","article-title":"Assessing the immunogenic response of a single center\u2019s pneumococcal vaccination protocol in sickle cell disease","volume":"38","author":"Santoro","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026061610565024600_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21645515.2019.1643677","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count","volume":"16","author":"Song","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"2026061610565024600_bib47","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/QAD.0000000000000755","article-title":"Persisting high prevalence of pneumococcal carriage among HIV-infected adults receiving antiretroviral therapy in Malawi: a cohort study","volume":"29","author":"Heinsbroek","year":"2015","journal-title":"AIDS"},{"key":"2026061610565024600_bib48","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2015.04.024","article-title":"Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine","volume":"33","author":"Madhi","year":"2015","journal-title":"Vaccine"},{"key":"2026061610565024600_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vaccine.2021.11.058","article-title":"Evaluation of effectiveness, safety and cost-benefit of the 23\u2013valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients","volume":"40","author":"Zou","year":"2022","journal-title":"Vaccine"},{"key":"2026061610565024600_bib50","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jiu819","article-title":"Quantitative and qualitative antibody responses to immunization with the pneumococcal polysaccharide vaccine in HIV-infected patients after initiation of antiretroviral treatment: results from a randomized clinical trial","volume":"211","author":"Rodriguez-Barradas","year":"2015","journal-title":"J Infect Dis"},{"key":"2026061610565024600_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/QAD.0000000000003126","article-title":"Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV","volume":"36","author":"Mohapi","year":"2022","journal-title":"AIDS"},{"key":"2026061610565024600_bib52","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/QAD.0000000000000385","article-title":"Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection","volume":"28","author":"Bamford","year":"2014","journal-title":"AIDS"},{"key":"2026061610565024600_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.19.1.20631","article-title":"Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy","volume":"19","author":"Cheng","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2026061610565024600_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijid.2021.03.072","article-title":"Invasive Pneumococcal Disease among adults with hematological and solid organ malignancies: a population-based cohort study","volume":"106","author":"Garrido","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026061610565024600_bib55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12879-018-3267-6","article-title":"Serologic response to pneumococcal vaccination in children experiencing recurrent IPD","volume":"18","author":"Ingels","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2026061610565024600_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2021.02.031","article-title":"Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogot\u00e1, Colombia","volume":"105","author":"Severiche-Bueno","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026061610565024600_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2018.08.002","article-title":"Measuring immune responses to pneumococcal vaccines","volume":"461","author":"LaFon","year":"2018","journal-title":"J Immunol Methods"},{"key":"2026061610565024600_bib58","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.vaccine.2017.05.039","article-title":"Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice","volume":"35","author":"Cotte","year":"2017","journal-title":"Vaccine"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article-pdf\/doi\/10.1093\/inthealth\/ihag058\/68533079\/ihag058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article-pdf\/doi\/10.1093\/inthealth\/ihag058\/68533079\/ihag058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:57:06Z","timestamp":1781621826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/advance-article\/doi\/10.1093\/inthealth\/ihag058\/8708745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":58,"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihag058","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"ihag058"}}